Elda Righi

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

Yuhui Huang, Jian‐Ping Yuan, Elda Righi et al. · Proceedings of the National Academy of Sciences · 2012 · 1K citations · Full text

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 731 citations · Full text

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>

Mario Tumbarello, Enrico Maria Trecarichi, Alberto Corona et al. · Clinical Infectious Diseases · 2018 · 340 citations · Full text

Epidemiological trends in nosocomial candidemia in intensive care

Matteo Bassetti, Elda Righi, Alessandro Costa et al. · BMC Infectious Diseases · 2006 · 333 citations · Full text

Physical activity: Benefits and challenges during the COVID‐19 pandemic

Michael John Dwyer, Margherita Pasini, Stefano De Dominicis et al. · Scandinavian Journal of Medicine and Science in Sports · 2020 · 278 citations · Full text

Physical Activity, Heart Failure, Vascular Disease +24